| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytomx Therapeutics, Inc. (CTMX) have been net sellers, shedding 1,624 shares worth roughly $5K on balance.
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.40M | - | |
| Other | 650.0K | $2.24M | - | |
| CFO | 295.3K | $1.02M | - | |
| Other | 100.0K | $344.0K | - | |
| Other | 87.5K | $301.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $28.12 | $84,360.00 | -38.8% | |
| Mar 26, 2018 | Gluck Frederick W | Director | Sell | 5,000 | $31.93 | $159,641.50 | -1.8% | |
| Mar 2, 2018 | Gluck Frederick W | Director | Sell | 16,181 | $30.00 | $485,465.60 | -5.5% | |
| Mar 2, 2018 | Humphrey Rachel | Chief Medical Officer | Sale+OE | 16,160 | $30.00 | $484,800.00 | -34.8% | |
| Mar 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 33,000 | $29.99 | $989,694.50 | -61.2% | |
| Mar 1, 2018 | McCarthy Sean A.67 | President And CEO | Sale+OE | 19,578 | $29.43 | $576,141.38 | -80.8% | |
| Feb 28, 2018 | Humphrey Rachel | Chief Medical Officer | Sale+OE | 23,840 | $30.00 | $715,200.00 | -44.1% | |
| Feb 28, 2018 | Gluck Frederick W | Director | Sell | 3,819 | $30.00 | $114,570.00 | -1.3% | |
| Feb 1, 2018 | Ray Debanjan | Chief Financial Officer | Sell | 2,548 | $26.69 | $68,009.94 | -35.0% | |
| Jan 5, 2018 | Gluck Frederick W | Director | Sell | 10,000 | $25.01 | $250,078.00 | -3.3% |